The Swiss stock markets finished to the downside on Tuesday. The market was rather directionless today, due to a lack of any significant news. The trading day was also rather quiet, due in part to the shortened trading week.
The Swiss Market Index fell by 0.65 percent Tuesday and closed at 6,258.66. The Swiss Leader Index declined by 0.62 percent and the Swiss Performance Index lost 0.52 percent.
The index heavyweights all closed lower Tuesday. Novartis and Roche both fell by 0.4 percent and Nestle lost 0.7 percent. Roche was impacted by news from its attempt to acquire U.S. company Illumina. Illumina sent a letter to its shareholders urging them to reject the Roche takeover bid, calling it a grossly inadequate price.
Bank stocks were weak Tuesday. UBS fell by 2.0 percent, Credit Suisse declined by 1.7 percent and Julius Baer dropped by 1.3 percent. Insurance stocks were modestly higher, with the exception of ZFS, which lost 0.9 percent. Baloise climbed by 1.5 percent, Swiss Life gained 0.6 percent and Swiss Re closed up by 0.1 percent.
Cyclical stocks were mixed during Tuesday's session. Holcim fell by 1.7 percent, Adecco declined by 0.9 percent and Schindler dipped by 0.5 percent. Lonza climbed by 1.61 percent after the company elected Richard Ridinger as its new chief executive officer. Kuehne + Nagel climbed by 0.4 percent and Sonova gained 0.7 percent.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.